Rescheduling Medical Marijuana - Implications for Criminal & Collateral Consequences Topic of White Paper From CRS
June 17, 2026
June 17, 2026
WASHINGTON, June 17 (TNSLrpt) -- The Congressional Research Service issued the following In Focus white paper (No. IF12715) by Lisa N. Sacco, illicit drugs and crime policy specialist:
* * *
Rescheduling Medical Marijuana: Implications for Criminal and Collateral Consequences
In 1970, the Controlled Substances Act (CSA) classified marijuana and its derivatives as Schedule I controlled substances. Since then, this classification largely remained unchanged un . . .
* * *
Rescheduling Medical Marijuana: Implications for Criminal and Collateral Consequences
In 1970, the Controlled Substances Act (CSA) classified marijuana and its derivatives as Schedule I controlled substances. Since then, this classification largely remained unchanged un . . .